Menu
Menu
J Clin Aesthet Dermatol. 2023;16(9):42–45. by Jerry Tan, MD; Zoe D. Draelos, MD; Melinda J. Gooderham, MSc, MD; Andrew F. Alexis, MD, MPH; Emmy Graber, MD, MBA; Jonette Keri, MD,
J Clin Aesthet Dermatol. 2021;14(10):42–47. by Lawrence F. Eichenfield, MD; Pearl Kwong, MD, PhD; Mercedes E. Gonzalez, MD; Albert Yan, MD; Pieter d’Arnaud, MS; Patrick Burnett, MD, PhD; and Melissa
J Clin Aesthet Dermatol. 2021;14(4):E53–E60. by Hilary E. Baldwin, MD; Lawrence J. Green, MD, FAAD; Leon Kircik, MD; Eric Pierre Guenin, PharmD, PhD, MPH; Anya Loncaric Forest, MS; and Radhakrishnan
J Clin Aesthet Dermatol. 2020;13(10):18–22 by Luis Puig, MD, PhD; Baojin Zhu, PhD; Russel Burge, PhD, MA; David Shrom, PhD; Yan Dong, PhD; Wei Shen, PhD; Lotus Mallbris, MD, PhD;
aAndrew F. Alexis, MD, MPH; bFran Cook-Bolden, MD; cTina Lin, PharmD aDepartment of Dermatology, Mount Sinai St. Luke’s and Mount Sinai West, New York, New York bSkin Specialty Dermatology and
James Q. Del Rosso, DO, FAOCD Clinical Professor (Dermatology), Adjunct Faculty, Touro University College of Osteopathic Medicine, Henderson, Nevada; Private Practice, Lakes Dermatology, Las Vegas, Nevada; Research Director, Del Rosso
James Q. Del Rosso, DO, FAOCD Las Vegas Dermatology, Las Vegas, Nevada; Touro University College of Osteopathic Medicine, Henderson, Nevada DISCLOSURE OF COMPANY RELATIONSHIPS: Dr. Del Rosso serves as a
Fran E. Cook-Bolden, MD Skin Specialty Dermatology, New York, New York Disclosure: Dr. Cook-Bolden was a principle investigator in the multicenter study and has been a consultant for Valeant Pharmaceuticals.
Diane Berson, MD, Weill Medical College of Cornell University, New York, New York; Andrew Alexis, MD, St. Luke’s Roosevelt Hospital, New York, New York
Peter Saitta, DO; Steven K. Grekin, DO, FAOCD Department of Dermatology, Oakwood Healthcare System, Trenton, Michigan Disclosure: The authors report no relevant conflicts of interest.
